Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

<p>Abstract</p> <p>Background</p> <p>More than 50% of hepatitis C viruses (HCV)-infected patients do not respond to the classical Interferon (IFN)/Ribavirin (RBV) combination therapy. The aim of this study was to evaluate the efficacy of retreatment with Peg-Interferon...

Full description

Bibliographic Details
Main Authors: Gonçales Neiva SL, Pavan Maria HP, Tozzo Raquel, Gonçales Eduardo SL, Angerami Adriana FCF, Vigani Aline G, Moma Camila A, Gonçales Fernando L
Format: Article
Language:English
Published: BMC 2010-07-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/10/212

Internet

http://www.biomedcentral.com/1471-2334/10/212

Similar Items